TEPR: CCHIT Meeting Draws Ire from Vendors, Ideas from Leaders


By Neil Versel

BALTIMORE -- A “town hall” meeting of the Certification Commission for Healthcare Information Technology (CCHIT) at the annual Towards the Electronic Patient Record (TEPR) conference here this week turned into a shouting match at times, as small health-IT vendors were not shy about voicing their displeasure with the new program to certify ambulatory electronic health records (EHRs).

Joe Byers, a vice president of Juno Beach, Fla.-based Document Storage Systems (DSS), vociferously argued that the certification program now in place will accelerate consolidation, leading to small companies like his being swallowed up by a handful of large vendors.

When reminded that the testing was voluntary, Byers complained that no one would buy a product without a CCHIT seal of approval. Indeed, commission member Robert Tennant, government affairs manager of the Medical Group Management Association (MGMA), said, “Our members will be looking for certification.”

Small vendors were particularly upset about Tennant’s statement that forthcoming exemptions to Medicare anti-kickback regulations and the Stark rules on physician self-referral to allow hospitals and healthcare systems to supply health-IT to affiliated doctors likely require EHRs to have CCHIT certification.

If the Stark exemption includes such a requirement, “That is, in effect, federal law,” said Bill Sivill, a health-IT consultant at the meeting. “You are the tail wagging the dog.”

Department of Health and Human Services (HHS) officials are not commenting on the content of the final rules, which are due out at any time. However, the American Health Information Community (AHIC) advisory board on May 16 recommended that HHS accept the certification process. CCHIT has a three-year, $2.7 million HHS contract to create and administer a certification program for commercial EHR products.

The commission published the new ambulatory EHR standards May 1 and took applications May 3-12 (see http://www.health-itworld.com/newsletters/2006/05/02/19877?page%3aint=-1). Commission chairman Mark Leavitt, M.D., said that his staff received more than two dozen applications during the 10-day window and that about 175 people applied to be testing jurors.

Certification testing for 2006 costs $28,000, regardless of the size of the vendor seeking approval. Of that, $23,200 goes to the actual testing process and $4,800 is the annual fee to maintain certification. Vendors may use a certification for up to three years as long as they pay the annual maintenance fee, though they may choose to re-test annually to get a current-year certification stamp.

The cost and the renewal process were key targets of vendor ire. Several vendors promised that they will raise their prices if they have to pay the $28,000 testing fee. They also worried about spending money for a full re-testing next year so as not to appear that their products were out of date with a 2006 sticker in 2007.

Leavitt tried to assuage concerns by saying that certification will help business. “If you don’t see an acceleration in the [EHR] market, then we’ve failed,” he said.

Leavitt said that feedback from the health-IT community is causing him to think about how the recertification process will work starting next year. The commission plans on revising its standards annually. Still to be determined is how much testing will be required for a 2006-certified vendor to meet updated criteria in 2007.

Leavitt added that fees could come down in subsequent years, but that depends on future funding for the commission.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.